p53 as a molecular target for cancer therapy

C. Ishioka, M. Osada, M. Gamo, R. Kanamaru

Research output: Contribution to journalArticle

1 Citation (Scopus)


Development of novel strategies is required for cancer treatment because most human tumors are refractory to current conventional therapy. During the past decade, a number of oncogenes and tumor suppressor genes have been cloned and the molecular mechanisms as to how mutations in such genes contribute to tumor development are going to be clarified. It is, therefore, a great challenge to develop novel strategies for tumor specific therapy based on molecular biology of cancer. p53 tumor suppressor gene is one of the most frequently mutated genes in a variety of human cancers. This review paper introduces several recent approaches related to the p53 as a molecular target of cancer treatment, including (i) p53 status and chemo- radiosensitivity, (ii) p53 gene therapy, (iii) E1B-deficient adenovirus and (iv) restoration of p53 function by synthetic polypeptides.

Original languageEnglish
Pages (from-to)2207-2212
Number of pages6
JournalJapanese Journal of Cancer and Chemotherapy
Issue number15
Publication statusPublished - 1997 Dec 1


  • Cancer treatment
  • P53
  • Tumor suppressor gene

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'p53 as a molecular target for cancer therapy'. Together they form a unique fingerprint.

  • Cite this

    Ishioka, C., Osada, M., Gamo, M., & Kanamaru, R. (1997). p53 as a molecular target for cancer therapy. Japanese Journal of Cancer and Chemotherapy, 24(15), 2207-2212.